期刊
NATURE CANCER
卷 3, 期 12, 页码 1418-1419出版社
NATURE PORTFOLIO
DOI: 10.1038/s43018-022-00484-w
关键词
-
类别
Recent progress in CAR T cell biology has improved our understanding of the mechanisms behind durable remissions in some patients. Additionally, promising clinical trial outcomes are being observed in the treatment of solid tumor malignancies using CAR T cells targeting B cell tumor antigens.
Recent progress indicates a considerably improved mechanistic understanding of CAR T cell biology and delivers important insights into why some patients achieve durable remissions and others do not. In addition, although most success has been achieved in the context of CAR T cells targeted to B cell tumor antigens, namely CD19 and BCMA, we are seeing promising clinical trial outcomes for solid tumor malignancies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据